US › Healthcare

Retension Pharmaceuticals, Inc. Common Stock (RTSN)

US · Healthcare · Biotechnology

$14.07+15.23%

Last close · 2026-10-16

Key statistics

Market cap

$97.0M

Forward P/E

0.0

P/B

0.00

Book value

$-18.48

EPS (TTM)

$-2.51

52-week high

$3,150.00

52-week low

$9.66

50-day MA

$11.28

200-day MA

$11.28

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Retension Pharmaceuticals, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.